MARKET

UTHR

UTHR

United Therapeutics Corp.
NASDAQ
368.30
-2.14
-0.58%
Opening 13:46 02/14 EST
OPEN
370.93
PREV CLOSE
370.44
HIGH
370.93
LOW
364.81
VOLUME
87.48K
TURNOVER
--
52 WEEK HIGH
417.82
52 WEEK LOW
210.64
MARKET CAP
16.44B
P/E (TTM)
16.19
1D
5D
1M
3M
1Y
5Y
1D
United Therapeutics (UTHR): Buy, Sell, or Hold Post Q3 Earnings?
Barchart · 14h ago
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?
NASDAQ · 1d ago
United Therapeutics: Growth Prospects and Financial Performance Support ‘Buy’ Rating
TipRanks · 1d ago
Weekly Report: what happened at UTHR last week (0203-0207)?
Weekly Report · 4d ago
Liquidia Corp.: We Have Exposure To The Upside Now
Seeking Alpha · 02/06 16:05
Notable ETF Outflow Detected - XBI, NBIX, ALNY, UTHR
NASDAQ · 02/05 16:06
United Therapeutics price target lowered to $460 from $475 at UBS
TipRanks · 02/05 12:40
Is United Therapeutics (NASDAQ:UTHR) Using Too Much Debt?
Simply Wall St · 02/05 11:00
More
About UTHR
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.

Webull offers United Therapeutics Corp stock information, including NASDAQ: UTHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UTHR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UTHR stock methods without spending real money on the virtual paper trading platform.